Hematology / Oncology CME Courses
The following CME/CE courses are available for credit on myCME. Simply click on any link below to get started.
This activity will increase the ability of hematology and oncology clinicians to incorporate the latest research and treatment recommendations for progressive or relapsed MM into their clinical practice, thus ensuring the best possible outcomes for each patient.
This activity offers:
1.00 / AMA PRA Category 1 CreditTM
Sign Up for Free e-newsletters
Breast Cancer Awareness Month Poll
Cancer Therapy Advisor Articles
- Will Epigenetic Drugs Improve Immunotherapy Outcomes?
- Preoperative Breast MRI Associated With Longer Wait Time to Surgery
- Nivolumab Extends Survival in Advanced Nonsquamous Lung Cancer
- Quitting Smoking Prior to Chemo Linked to Improved Survival Rate in Stage 4 Lung Cancer
- PD-L1 May Predict Response to TKIs, VEGFs in Metastatic Clear Cell Renal Cell Carcinoma
- Identifying Allele Mismatch in aGVHD With Genome-Wide Surveillance
- Preop Proteinuria Predicts Overall Survival in Kidney Cancer
- Partner-assisted Skin Exams Benefit Some More Than Others
- New Staging System for Intrahepatic Cholangiocarcinoma May Benefit Potential Surgery Patients
- Volume Re-classification Portends Grade Re-classification in Gleason 6 Prostate Cancer
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|